Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062264 · ClinicalTrials.gov registry record · NA
Patient Portal Flu Vaccine Reminders (RCT 6)
A NA study of Influenza and Respiratory Tract Infections, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 22,233
- Enrollment target
- 1
- Study location
NCT06062264: Completed NA study of Influenza and Respiratory Tract Infections, sponsored by University of California, Los Angeles.
NCT06062264 is a NA study of Influenza and Respiratory Tract Infections that has completed, run by University of California, Los Angeles. The registered enrollment target is 22,233 participants, below the 36,661-participant average among 156 other Influenza trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062264, a NA study of Influenza and Respiratory Tract Infections, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 22,233 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is taking place in Los Angeles, CA at 21 clinics within the UCLA Health System. The study design is a 3 arm randomized trial. Patients will be randomized into 1) receiving portal based reminder messages with a video from their PCP encouraging them to receive the influenza vaccine, 2) portal-based reminder messages with an infographic with the image of their PCP encouraging them to receive the influenza vaccine, or 3) the control group. Patients randomized to the intervention arms will receive reminders if they are due for influenza vaccine. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and \>65 yrs. (63%). The investigators will assess the effectiveness of MyChart R/R video messages and infographic messages as compared to the standard of care control (Health system messages).
Primary Outcome
Percent of patients with annual influenza vaccination (between 10/4/23 - 4/1/24) among adult patients. Outcomes will be assessed via vaccine data extraction from the electronic health record and external claims and pharmacy data. The index patients must also be an active UCLA Health MyChart user (\>= 1 login over the last 12 months from 8/1/23, excluding activity on the user's initial profile activation date). Individuals not affiliated with any primary care practice will be excluded from the p
Conditions Studied
Interventions
- BEHAVIORAL Portal-based Video Message
- BEHAVIORAL Portal-based Infographic Message
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,233 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT06062264 record still lists
NCT06062264 is an interventional study that assigns participants to a tested intervention. Its 22,233 participants enrollment target places it among the larger protocols in the corpus, below the 36,661-participant average among 156 other Influenza trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Portal-based Video Message is the first listed.
NCT06062264 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06062264 about?
NCT06062264 is a clinical study titled "Patient Portal Flu Vaccine Reminders (RCT 6)". This trial is taking place in Los Angeles, CA at 21 clinics within the UCLA Health System. The study design is a 3 arm randomized trial. Patients will be randomized into 1) receiving portal based reminder messages with a video from their PCP encouraging them to receive the influenza vaccine, 2) por...
What is the current status of trial NCT06062264?
This trial is currently completed. It is a NA study. The enrollment target is 22,233 participants. The study started on 2023-10-03. Estimated completion is 2024-04-01.
What conditions does trial NCT06062264 study?
This clinical trial studies the following conditions: Influenza, Respiratory Tract Infections.
What interventions are being tested in trial NCT06062264?
The interventions under investigation include: Portal-based Video Message (BEHAVIORAL), Portal-based Infographic Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT06062264?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06062264 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06062264's enrollment target sits among peer trials
22,233 8th of 156 higher than 149 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI